Welcure Drugs And Pharmaceuticals Ltd. Press Release Jun 17 2025
Filed with BSE · · 8 pages · English
Welcure Drugs and Pharmaceuticals Ltd. on 6ix
Story so far
Earlier from Welcure Drugs and Pharmaceuticals
- Welcure Drugs And Pharmaceuticals Ltd. Press Release May 29 2025
- Compliances-Reg.24(A)-Annual Secretarial Compliance
- Announcement Pursuant To Regulation 32 Of SEBI (LODR) Regulations, 2015 - Non Applicability Of Filing Statement Of Deviation / Variation In Utilization Of Funds For Quarter And Year Ended 31St March, 2025
- Announcement under Regulation 30 (LODR)-Change in Management
- Audited Standalone Financial Results And Audited Standalone Financial Statements Along With Auditor'S Report Of The Company For The Quarter And Year Ended March 31, 2025
Later from Welcure Drugs and Pharmaceuticals
- Intimation Under Regulation 30 - Rs. 517 Crore Global Sourcing Mandate
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Jun 18 2025
- Closure of Trading Window
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Jun 27 2025
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Jun 30 2025
Follow Welcure Drugs and Pharmaceuticals into a list and get an email when it puts out news.
Follow Welcure Drugs and Pharmaceuticals